Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab

Ann Hematol. 2023 Jan;102(1):245-247. doi: 10.1007/s00277-022-05035-y. Epub 2022 Nov 17.

Authors

Tim Strüßmann¹, Johannes Jung², Jürgen Heinz², Jesus Duque Afonso², Ralph Wäsch², Monika Engelhardt², Justus Duyster², Jürgen Finke², Reinhard Marks²

Affiliations

¹ Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany. [email protected].
² Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal / therapeutic use
Humans
Platelet Count
Purpura, Thrombocytopenic, Idiopathic* / therapy
Remission Induction

Substances

daratumumab
Antibodies, Monoclonal